Abstract
Heart transplantation (HTx) has become standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-HTx care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of HTx recipients. However, limitations to long-term allograft survival exist, including rejection, infection, coronary allograft vasculopathy, and malignancy. Careful balance of immunosuppressive therapy and vigilant surveillance for complications can further improve long-term outcomes of HTx recipients.
| Original language | English |
|---|---|
| Pages (from-to) | 565-589 |
| Number of pages | 25 |
| Journal | Korean Circulation Journal |
| Volume | 48 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2018 |
Bibliographical note
Publisher Copyright:Copyright © 2018. The Korean Society of Cardiology.
Keywords
- Current practice
- Forecasting
- Heart failure
- Heart transplantation
- History